In UALCAN databases, we found that higher expression of LPAR2 was associated with improved prognosis in patients with ACC (P = 0.00055), as well as with worse prognosis with KIRC (P < 0.0001) (Fig. 5G, I). The gene discussed is LPAR2; the disease is adrenal cortex carcinoma.